Asimily vs Cynerio
Updated October 22, 2026
Hospitals run thousands of networked devices, from infusion pumps to imaging systems, and many of them cannot take ordinary security software or be patched on short notice. Asimily and Cynerio both find those devices and rank their risks, but each puts its weight in a different place: Asimily centers on a shared remediation list that biomedical engineering and security work together, while Cynerio leans on finding clinical devices and judging risk by its effect on patient care. Your team's weaker area today, coordinating fixes or seeing clinical devices clearly, points to the better fit.
Our analysts compared Asimily and Cynerio on their main job, the hospital each suits, device discovery, risk ranking, and rollout, using the HIR review of each company and each vendor's own site. In the following sections, we compare them in one table and describe the hospital each one suits.
Asimily vs Cynerio at a glance, October 2026
| What buyers weigh | Asimily | Cynerio |
|---|---|---|
| Pricing model | A platform license, usually set by device count or number of sites. | Usually priced by beds, sites, or the number of devices found. |
| What drives cost | Devices and sites covered, the sensors or collectors you need, and consulting. | Network sensor hardware and setup services. |
| Main job | Inventories connected medical devices and helps biomed and security teams rank which risks to fix. | Finds infusion pumps, imaging gear, and monitors on the network and ranks weaknesses by their effect on patient care. |
| Best-suited hospital | Health systems where biomedical engineering and security work from one list of fixes. | Device-heavy hospitals whose medical devices still share a network with other IT systems. |
| Results | Scores 7.3 for reducing device risk. | Scores 7.6 for finding clinical devices on the network. Higher score |
| Risk ranking | Scores 7.4 for device security depth. | Scores 7.4 for ranking which risks to fix first. |
| Rollout | Scores 6.8 for discovery and remediation setup. | Scores 7.0 for knowing which ward a device is on. |
| Time to full value | About 7 to 15 months | About 7 to 15 months |
| What you need first | Biomed and security teams that agree on who fixes each device. | A real number of connected medical devices (infusion, imaging, monitoring, and similar). |
| Deal-breaker | Your real need is clinician sign-on, which is an identity product job. | You run outpatient sites with few connected clinical devices. |
| Pricing clarity score | 6.9 | 6.8 |
| HIR overall score | 7.2, Recommend. | 7.3, Recommend. |
| Best for | Health systems where biomedical engineering and security teams together want to list connected medical devices and rank their risks. | Health systems with many connected infusion, imaging, and monitoring devices. |
| Not a fit for | Buyers whose main need is clinician sign-in and single sign-on, which is Imprivata's area. | Outpatient groups with few connected medical devices. |
Which fits which buyer
Start with where your device program stalls today.
Choose Asimily if
- Your biomed and security teams need one shared list of fixes.
- You want to fix device risks without taking clinical equipment offline needlessly.
- You are comparing device security vendors on how fixes are tracked.
Choose Cynerio if
- You run many connected infusion, imaging, and monitoring devices.
- You want risks ranked by their effect on patient care.
- Your medical devices and IT systems still share one network.
Verdict
The scores are close, with Cynerio slightly ahead on finding clinical devices. Cynerio fits device-heavy hospitals that need to see what is on the network first, and Asimily fits health systems whose biomed and security teams are ready to work one remediation list together.
Run each on a sample of your own network before you sign, since neither posts prices and results depend on what each tool finds.
Methodology
Each row comes from the HIR reviews of Asimily and Cynerio, scored under the HIR method, and from each vendor's public pricing where it exists. Any published price for Asimily or Cynerio was checked on that vendor's own site on October 22, 2026.
A green check marks a clear edge for Asimily or Cynerio only where their review scores differ by at least 0.3 points or the two reviews show a plain difference. Rows with nothing published for either Asimily or Cynerio are left out, and time to full value for each adds up the rollout stages in its review.